This record was last updated April 15, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
Due to limited resources such as the low therapist to patient ratio or high costs associated to rehabilitation therapy, providing higher therapy dose to patients after discharge is highly challenging. This often results in non-use of the impaired limb as a result of the decreased therapy dose, causing partial loss of the functional improvements previously gained during early rehabilitation.
In this study, the investigators plan to pilot the HomeRehab Gym concept via the deployment of three rehabilitation devices at patients' homes: MyoPanda, H-Man and ReHandyBot.
Protocol Amendment History
2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-05-06; most recent amendment 2025-04-10.
Status change: Not Yet Recruiting → Recruiting2025-04-10